Chlormadinone acetate
- Generic Name
- Chlormadinone acetate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H29ClO4
- CAS Number
- 302-22-7
- Unique Ingredient Identifier
- 0SY050L61N
- Background
Chlormadinone acetate is a progesterone derivative first synthesized in 1961. In the US, chlormadinone acetate was formerly marketed as a component of the combination drug products Estalor-21 and C-Quens. However, the use of these drugs was associated with the development of mammary tumors in dogs. In 1972, the FDA withdrew its approval for the use of chlormadinone acetate in all products. Chlormadinone acetate continues to be used in other countries due to its high contraceptive efficacy and tolerability.
- Associated Conditions
- -
- Associated Therapies
- -
Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2010-05-14
- Last Posted Date
- 2011-11-03
- Lead Sponsor
- University Hospital of North Norway
- Target Recruit Count
- 40
- Registration Number
- NCT01123538
- Locations
- 🇳🇴
Gynecology center, Helse Nord, Bodø, Norway
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath